1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of cytosine deaminase with uracil phosphoribosyl transferase with 5-fluorocytosine radiosensitizes rat prostate cancer cells
    Meeting Abstract

    Xing, L.; Deng, X.; Gade, T. P. F.; Ling, C. C.; Koutcher, J. A.; Li, G. C.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Scientific rationale and clinical development of sunitinib malate
    Meeting Abstract

    Ueda, E.; Casali, P. G.; Demetri, G. D.; Hudes, G. R.; Kulke, M. H.; Miller, K. D.; Motzer, R. J.; Baum, C. M.
    Clinical and Experimental Metastasis (2007)

    Fulltext@MSK | Save
  • Carbonic anhydrase (CA9) expression in clear cell (conventional) renal cell carcinoma (CRCC): Comparison of a commercially available antibody with a previously frequently utilized, research-based antibody
    Meeting Abstract

    Tickoo, S. K.; Al-Ahmadie, H. A.; Alden, D.; Olgac, S.; Fine, S. W.; Gopalan, A.; Russo, P.; Motzer, R. J.; Reuter, V. E.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Carbonic anhydrase (CA9) expression in clear cell (conventional) renal cell carcinoma (CRCC): Comparison of a commercially available antibody with a previously frequently utilized, research-based antibody
    Meeting Abstract

    Tickoo, S. K.; Al-Ahmadie, H. A.; Alden, D.; Olgac, S.; Fine, S. W.; Gopalan, A.; Russo, P.; Motzer, R. J.; Reuter, V. E.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Targeting MEK in tumors with BRAF and RAS mutations
    Meeting Abstract

    Solit, D.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Dulude, H.; Pancha, C.; Czanny, M.; Curley, T.; Morris, M.; Rathkopf, D.; Schwartz, L.; Heller, G.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) as a predictor of response in head and neck squamous cell carcinoma (HNSCC): Initial analysis
    Meeting Abstract

    Shukla-Dave, A.; Lee, N.; Wang, Y.; Stambuk, H.; Karimi, S.; Shah, J. P.; Pfister, D. G.; Koutcher, J. A.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma
    Meeting Abstract

    Rixe, O.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Kim, S. T.; Chen, I.; Figlin, R. A.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Sunitinib vs. interferon-alpha (IFN-alpha) in first-line metastatic renal cell carcinoma (mRCC): An economic evaluation
    Meeting Abstract

    Remak, E.; Brown, R.; Negrier, S.; Motzer, R. J.; Kim, S. T.; Charbonneau, C.
    Value in Health (2007)

    Fulltext@MSK | Save
  • Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Redman, B. G.; Hudes, G. R.; Kondagunta, G. V.; Patel, P. H.; Kim, S. T.; Chen, I.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save